Rubicon Organics Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEDI. From 24 October 2025 to 24 October 2026, the disclosure feed for Rubicon Organics Inc. logged 59 filings by 5 insiders.
Open-market activity splits into 41 purchases totalling €46k and 13 sales totalling €95k; 2 insiders sit on the buying side and 2 insiders on the selling side. The net balance comes to €48k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Boggio, Lenard filed the largest sale, €19k, on 16 September 2026, which represents 0.10% of the company's market value. Among those who bought: 2 senior executives.
The last insider purchase was made public on 23 July 2026, 92 days ago. Publication is fast: at least half of the trades appear on SEDI on the same day. That lag is the time during which only the insider knows about the trade.
Compared with its exchange (2,685 companies, median 14 filings), a count of 59 filings is above the norm. Our records for Rubicon Organics Inc. go back to 2018, with 315 purchases and 19 sales on the open market in total.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 412 declarations
Rubicon Organics Inc. is a Canadian company focused on the cultivation and sale of organic cannabis. It is listed on the Toronto Stock Exchange under the symbol XTSE.